Ansell is experiencing good sales growth this year, driven by the US. Positive EBIT margin growth is supported by operational and supply chain improvements. The company maintained adjusted fiscal 2027 EPS guidance of USD 1.58 to USD 1.70.
Expansion in clean room and surgical, a niche where Ansell’s products are more differentiated, earns materially higher margins than its other businesses, supporting group margin growth.
Cost pressures such as tariffs and supply chain disruptions weigh on operations, without certainty that price pass-throughs will succeed.
Metric | ANN | RKT | BDX |
|---|---|---|---|
Price/Earnings (Normalized) | 16.25 | 20.98 | 31.19 |
Price/Book Value | 2.23 | 6.39 | 2.41 |
Price/Sales | 2.11 | 2.71 | 3.14 |
Price/Cash Flow | 13.18 | 15.25 | 16.70 |
Metric | ANN | RKT | BDX |
|---|---|---|---|
Quick Ratio | 1.14 | 0.38 | 0.33 |
Current Ratio | 2.30 | 0.59 | 0.87 |
Interest Coverage | 7.09 | 8.84 | 4.15 |
Metric | ANN | RKT | BDX |
|---|---|---|---|
Return on Assets (Normalized) | 6.41% | 9.05% | — |
Return on Equity (Normalized) | 10.75% | 33.99% | — |
Return on Invested Capital (Normalized) | 8.69% | 15.92% | — |
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc ISRG | LOCK|<@?VjG$@ | LOCK|%t | $154B | |||
| Becton Dickinson & Co BDX | LOCK|SK | LOCK|wvmfx | $59B | |||
| Alcon Inc ALC | LOCK|<RNR!vX | LOCK|<ZC&^ | $35B | |||
| Medline Inc Ordinary Shares - Class A MDLN | LOCK|z%<L&TD | LOCK|@<>zC | $35B | |||
| ResMed Inc RMD | LOCK|<m>!<p! | LOCK|>b%z! | $34B | |||
| West Pharmaceutical Services Inc WST | LOCK|W>k$L!B | LOCK|?xh | $29B | |||
| Solventum Corp SOLV | LOCK|%%<L^Q& | LOCK|&Qm | $15B | |||
| Baxter International Inc BAX | LOCK|^> | LOCK|ZZKP | $13B | |||
| The Cooper Companies Inc COO | LOCK|&RD^q%f | LOCK|@c^?f | $12B | |||
| Align Technology Inc ALGN | LOCK|k#pqVMN | LOCK|lWhSQ | $12B |
United States